Teva Pharma (TEVA) PT Lowered to $14 at Susquehanna
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $38.98 -0.54%
Rating Summary:
18 Buy, 21 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
18 Buy, 21 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Susquehanna lowered its price target on Teva Pharma (NYSE: TEVA) to $14.00 (from $20.00) while maintaining a Positive rating.
Analyst Andrew Finkelstein notes Q3 showed further challenges.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva shares Phase 3 data on once-monthly schizophrenia injection
- Lasertec Corp. (6920:JP) (LSRCF) PT Raised to JPY41,800 at Nomura/Instinet
- Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY7,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
